Literature DB >> 15474719

Immune response to the Chlamydia trachomatis outer membrane protein PorB.

Diane E Kawa1, Julius Schachter, Richard S Stephens.   

Abstract

The antigenicity of the outer membrane protein PorB during exposure to Chlamydia trachomatis was evaluated in humans and its immunogenicity was tested in mice. Although natural human infection resulted in strong serological responses to the major outer membrane protein (OmpA), antibodies to PorB were low or absent. Analogous to the responses observed in humans, mice inoculated with EB or challenged with EB produced weak anti-PorB antibody responses. PorB immunization of mice previously exposed to EB elicited strong PorB antibody responses. These findings support the fact that OmpA antibodies dominate the humoral immune response during natural infections and demonstrate that immunization with PorB overcomes the lack of immune response to PorB elicited during natural infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474719     DOI: 10.1016/j.vaccine.2004.04.035

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Authors:  Christina M Farris; Richard P Morrison
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.

Authors:  F O Eko; D N Okenu; U P Singh; Q He; C Black; J U Igietseme
Journal:  Vaccine       Date:  2011-03-21       Impact factor: 3.641

3.  Induction of immune memory by a multisubunit chlamydial vaccine.

Authors:  F O Eko; E Ekong; Q He; C M Black; J U Igietseme
Journal:  Vaccine       Date:  2010-12-22       Impact factor: 3.641

4.  The ompA gene in Chlamydia trachomatis differs in phylogeny and rate of evolution from other regions of the genome.

Authors:  Brian W Brunelle; George F Sensabaugh
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 5.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

6.  CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.

Authors:  Christina M Farris; Sandra G Morrison; Richard P Morrison
Journal:  Infect Immun       Date:  2010-07-26       Impact factor: 3.441

7.  Toll-like receptor 2-dependent activity of native major outer membrane protein proteosomes of Chlamydia trachomatis.

Authors:  Paola Massari; Deana N Toussi; Delia F Tifrea; Luis M de la Maza
Journal:  Infect Immun       Date:  2012-11-06       Impact factor: 3.441

8.  BLAST screening of chlamydial genomes to identify signature proteins that are unique for the Chlamydiales, Chlamydiaceae, Chlamydophila and Chlamydia groups of species.

Authors:  Emma Griffiths; Michael S Ventresca; Radhey S Gupta
Journal:  BMC Genomics       Date:  2006-01-25       Impact factor: 3.969

9.  A novel transport mechanism for MOMP in Chlamydophila pneumoniae and its putative role in immune-therapy.

Authors:  Francis O Atanu; Ernesto Oviedo-Orta; Kimberly A Watson
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

10.  Seroprevalence of antibodies against Pkn1, a novel potential immunogen, in Chlamydia trachomatis-infected Macaca nemestrina and human patients.

Authors:  Achchhe L Patel; Prashant K Mishra; Divya Sachdev; Uma Chaudhary; Dorothy L Patton; Daman Saluja
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.